Fresenius Medical Care AG (MEX:FME N) Beneish M-Score: -2.77 (As of Jun. 25, 2026)


MEX:FME N Fresenius Medical Care AG MEX:FME N
50 GF Score
Price MXN778.14
GF Value MXN1,677.25
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Fresenius Medical Care AG Beneish M-Score?

Fresenius Medical Care AG MEX:FME N 50 Beneish M-Score is -2.77 as of Jun. 25, 2026. GuruFocus rates MEX:FME N with a GF Score™ of 50/100 and a GF Value™ of MXN1,677.25 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 632 Healthcare Providers & Services companies, Fresenius Medical Care AG ranks better than 65.19% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.77 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Fresenius Medical Care AG's Beneish M-Score or its related term are showing as below:

MEX:FME N' s Beneish M-Score Range Over the Past 10 Years
Min: -3.37   Med: -2.72   Max: -2.2
Current: -2.77

During the past 13 years, the highest Beneish M-Score of Fresenius Medical Care AG was -2.20. The lowest was -3.37. And the median was -2.72.


Fresenius Medical Care AG Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Fresenius Medical Care AG's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fresenius Medical Care AG Beneish M-Score Chart

Fresenius Medical Care AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.49 -2.59 -2.78 -2.71 -2.83

Fresenius Medical Care AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.77 -2.94 -2.73 -2.83 -2.77

MEX:FME N vs HCA, THC, DVA: Beneish M-Score Comparison

For the Medical Care Facilities subindustry, Fresenius Medical Care AG's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresenius Medical Care AG Beneish M-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Fresenius Medical Care AG's Beneish M-Score falls into.


MEX:FME N
50GF Score
Fresenius Medical Care AG MEX:FME N
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fresenius Medical Care AG Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Fresenius Medical Care AG for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9862+0.528 * 0.9424+0.404 * 0.9888+0.892 * 0.9886+0.115 * 0.9236
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9792+4.679 * -0.057471-0.327 * 1.0692
=-2.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was MXN77,456 Mil.
Revenue was 96149.668 + 106886.916 + 105174.49 + 104064.732 = MXN412,276 Mil.
Gross Profit was 24588.931 + 29272.377 + 26745.887 + 26373.064 = MXN106,980 Mil.
Total Current Assets was MXN169,027 Mil.
Total Assets was MXN656,007 Mil.
Property, Plant and Equipment(Net PPE) was MXN134,324 Mil.
Depreciation, Depletion and Amortization(DDA) was MXN33,368 Mil.
Selling, General, & Admin. Expense(SGA) was MXN64,545 Mil.
Total Current Liabilities was MXN140,291 Mil.
Long-Term Debt & Capital Lease Obligation was MXN180,131 Mil.
Net Income was 2450.133 + 6896.099 + 5916.586 + 4892.334 = MXN20,155 Mil.
Non Operating Income was -1862.893 + 946.269 + -542.876 + 670.684 = MXN-789 Mil.
Cash Flow from Operations was 4729.925 + 21119.505 + 15966.322 + 16829.656 = MXN58,645 Mil.
Total Receivables was MXN79,445 Mil.
Revenue was 107962.986 + 111043.762 + 104027.767 + 93995.302 = MXN417,030 Mil.
Gross Profit was 26186.009 + 27744.152 + 25046.324 + 23003.443 = MXN101,980 Mil.
Total Current Assets was MXN176,000 Mil.
Total Assets was MXN724,000 Mil.
Property, Plant and Equipment(Net PPE) was MXN154,393 Mil.
Depreciation, Depletion and Amortization(DDA) was MXN34,765 Mil.
Selling, General, & Admin. Expense(SGA) was MXN66,676 Mil.
Total Current Liabilities was MXN120,468 Mil.
Long-Term Debt & Capital Lease Obligation was MXN210,271 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(77455.804 / 412275.806) / (79445.405 / 417029.817)
=0.187874 / 0.190503
=0.9862

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(101979.928 / 417029.817) / (106980.259 / 412275.806)
=0.244539 / 0.259487
=0.9424

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (169026.918 + 134323.852) / 656006.548) / (1 - (175999.639 + 154392.705) / 723999.862)
=0.53758 / 0.543657
=0.9888

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=412275.806 / 417029.817
=0.9886

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(34764.802 / (34764.802 + 154392.705)) / (33368.206 / (33368.206 + 134323.852))
=0.183788 / 0.198985
=0.9236

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(64544.68 / 412275.806) / (66675.819 / 417029.817)
=0.156557 / 0.159883
=0.9792

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((180131.059 + 140290.654) / 656006.548) / ((210271.237 + 120468.166) / 723999.862)
=0.488443 / 0.456822
=1.0692

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(20155.152 - -788.816 - 58645.408) / 656006.548
=-0.057471

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Fresenius Medical Care AG has a M-score of -2.83 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.77 mean?
Fresenius Medical Care AG (MEX:FME N) has a Beneish M-Score of -2.77 as of Jun. 25, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Fresenius Medical Care AG and its competitors. According to the industry distribution chart, Fresenius Medical Care AG ranks #220 out of 632 companies in the Healthcare Providers & Services industry, placing it in the top 34.8%.
Is Fresenius Medical Care AG's Beneish M-Score too high?
Fresenius Medical Care AG's current Beneish M-Score is -2.77. Based on the distribution chart, Fresenius Medical Care AG ranks #220 out of 632 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Fresenius Medical Care AG has a GF Score™ of 50/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Fresenius Medical Care AG's Beneish M-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius Medical Care AG ranks #220 out of 632 companies for Beneish M-Score. This puts Fresenius Medical Care AG in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Providers & Services company?
A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Fresenius Medical Care AG and its competitors. Fresenius Medical Care AG's current Beneish M-Score is -2.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius Medical Care AG stock overvalued right now?
Based on GuruFocus' analysis, Fresenius Medical Care AG (MEX:FME N) is currently considered Possible Value Trap. The stock's GF Value™ is MXN1,677.25, compared to a current price of MXN778.14 — trading 53.6% below its estimated fair value. The current Beneish M-Score is -2.77. Fresenius Medical Care AG's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Fresenius Medical Care AG (MEX:FME N), the current Beneish M-Score is -2.77 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fresenius Medical Care AG (MEX:FME N) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius Medical Care AG stock appears to be undervalued. The current stock price of MXN778.14 is trading 53.6% below its estimated GF Value™ of MXN1,677.25. GuruFocus considers Fresenius Medical Care AG to be Possible Value Trap.

Key valuation signals for MEX:FME N:

  • Beneish M-Score: -2.77
  • GF Value™: MXN1,677.25 vs. price of MXN778.14 (53.6% below fair value)
  • GF Score™: 50/100 with 4 warning signs

No single metric tells the full story. See the MEX:FME N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fresenius Medical Care AG Business Description

Address Else-Kroner-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
50GF Score

Get the complete analysis for MEX:FME N

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN778.14
Price
MXN1,677.25
GF Value